Sort
48,018 grants matching “immunotherapy”
Effects of systemic and topical perturbations on human microbes
$1,077,460Heidi Kong · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Seattle Clinical Trials Unit
$1,077,209Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Integrating systems immunology with immunometabolism and cancer immunity
$1,077,000Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2025 · CA
Vaccine and radiation for the therapy of human cancers
$1,076,634James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$1,075,984Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Neutralizing Botulinum Neurotoxin with Human Antibodies
$1,075,856Rae Lyn Burke · Sri International · U01 · FY2008 · AI
UChicago Interdisciplinary Cancer Health Disparities SPORE
$1,075,670Olufunmilayo I Olopade · University Of Chicago · P20 · FY2018 · CA
UChicago Interdisciplinary Cancer Health Disparities SPORE
$1,075,670Olufunmilayo I Olopade · University Of Chicago · P20 · FY2020 · CA
Cancer Biomaterials Engineering
$1,074,592Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Characterization and improvement of graft versus leukemia effects
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Immunobiology and immunotherapy of leukemia
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$1,074,235Donald L Morton · Saint John'S Cancer Institute · P01 · FY2010 · CA
Investigate Proviral and Transgene Copy Numbers in Single Cells
$1,073,659Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vaccine strategies for HIVAIDS
$1,073,604Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
iPS cell based immunotherapy for malignant gliomas
$1,073,572John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$1,073,526St. Jude Children'S Research Hospital · U01 · FY2000 · AI
Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer
$1,072,330Christian Shenouda · Immunicom, Inc. · R44 · FY2022 · CA
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,071,960Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · CA
Cancer-cell specific therapy: photo-immunotherapy
$1,071,513Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Multiscale Mathematical Modeling of Cancer Progression
$1,070,597Vito Quaranta · Vanderbilt University · U54 · FY2012 · CA
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,070,151Allan D. Kirk · Duke University · U01 · FY2020 · AI
Humanized Monoclonal Antibody to Treat Acinetobacter Infections
$1,070,000Khalid Islam · Biological Anti-Infective Medicines, Llc · R42 · FY2017 · AI
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,069,555Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
A STINGing vaccine for TB
$1,068,965William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,068,000Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2021 · CA